Antibacterial Activity of Calozeyloxanthone Isolated from Calophyllum Species Against Vancomycin-Resistant Enterococci (VRE) and Synergism with Antibiotics

Abstract

Calozeyloxanthone (1) was re-isolated from the root bark of Calophyllum moonii, an endemic species of Sri Lanka, and found to be active against vancomycin-resistant Enterococci (VRE) and vancomycin-sensitive Enterococci (VSE) with MIC values of 6.25μg/ml and 12.5μg/ml, respectively. Further, a marked synergism between 1 and vancomycin hydrochloride (VCM) against VRE was also observed. These findings suggest that 1 in combination with VCM against VRE may be useful in controlling VRE infections.

References

• 1 Emori T G, Gaynes R P. An overview of nosocomial infections, including the role of the microbiology laboratory.  Clinical Microbiology Review. 1993;  6 428-42
• 2 Leclercq R, Courvalin P. Resistance to glycopeptides in enterococci.  Clinical Infectious Diseases. 1997;  24 545-56
• 3 Murry B E. Vancomycin-resistant enterococci.  American Journal of Medicine. 1997;  102 284-93
• 4 Moellering R C. Vancomycin-resistant enterococci.  Clinical Infectious Diseases. 1998;  26 1196-9
• 5 Garner J S. Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals.  Infection Control Hospital Epidemiology. 1996;  17 53-80
• 6 Slaughter S, Hayden M K, Nathan C, Hu T C, Rice T, Van Voorhis J, Matushek M, Franklin C, Weinstein R A. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit.  Annals of Internal Medicine. 1996;  125 448-56
• 7 Montecalvo M A, Jarvis W R, Uman J, Shay D V, Petrullo C, Rodney K, Gedris C, Horowitz H W, Wormser G P. Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting.  Annals of Internal Medicine. 1999;  131 269-72
• 8 Nourse C, Byrne C, Murphy H, Kaufman M E, Clarke A, Butler K. Eradication of vancomycin-resistant Enterococcus faecium from a pediatric oncology unit and prevalence of colonization in hospitalized and community-based children.  Epidemiology Infection. 2000;  124 53-9
• 9 Dharmaratne H RW, Wijesinghe W MNM. A trioxygenated diphenylated chromenxanthone from Calophyllum moonii .  Phytochemistry. 1997;  46 1239-95
• 10 Dharmaratne H RW, Wijesinghe W MNM, Thevanasem V. Antimicrobial activity of xanthones from Calophyllum species, against methicillin-resistant Staphylococcus aureus (MRSA).  Journal of Ethnopharmacology. 1999;  66 339-42
• 11 Goto S, Yo K, Kawakita R, Kosakai N, Mitsuhashi S, Nishino T, Ohsawa N, Tanami H. Re-revision of the method of minimum inhibitory concentration (MIC).  Chemotherapy. 1981;  29 76-9
• 12 Didry N, Dubreuil L, Pinkas M. Microbiological properties of protoanemonin isolated from Ranunculus bulbosus .  Phytotherapy Research. 1993;  7 21-4